Allspring Global Investments Holdings, LLC

Position in NRIX — Nurix Therapeutics, Inc.

CIK 1890906 CHARLOTTE, NC

Position in NRIX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$335,855

+$128,001 QoQ

Shares Held

13,844

+3.2% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#145

of 210 holders

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 33% Shared 0% None 67%

Healthcare · as of Jun 30, 2026

Allspring Global Investments Holdings, LLC holds $767,651,533 across 75 Biotechnology names. NRIX ranks #55 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	170,829	$158,490,019
2	EXEL	Exelixis, Inc.	1,998,471	$108,736,806
3	VRTX	Vertex Pharmaceuticals Inc / Ma	140,631	$69,855,635
4	BBIO	BridgeBio Pharma, Inc.	742,547	$55,304,900
5	ASND	Ascendis Pharma A/S	178,738	$47,672,997
6	CORT	Corcept Therapeutics Inc	523,192	$45,491,543
7	REGN	Regeneron Pharmaceuticals, Inc.	69,700	$43,460,737
8	MDGL	Madrigal Pharmaceuticals, Inc.	67,668	$36,334,331

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$335,855	13,844	+3.2%	Shares	Defined	2026-08-13
2026-03-31	$207,854	13,410	-85.1%	Shares	Defined	2026-05-05
2024-12-31	$1,694,092	89,920	-35.9%	Shares	Defined	2025-01-29
2024-09-30	$3,151,934	140,273	+13679.3%	Shares	Defined	2024-10-18
2023-12-31	$10,505	1,018	-17.6%	Shares	Defined	2024-01-25
2023-09-30	$9,707	1,235	-76.5%	Shares	Defined	2023-10-27
2023-06-30	$52,587	5,264	+328.7%	Shares	Defined	2023-07-18
2023-03-31	$10,904	1,228	+36.3%	Shares	Defined	2023-04-13
2022-12-31	$9,892	901	-2.2%	Shares	Defined	2023-01-23
2022-09-30	$12,000	921	-41.1%	Shares	Defined	2022-10-26
2022-06-30	$19,803	1,563	-78.2%	Shares	Defined	2022-07-25
2022-03-31	$100,507	7,174	+16.1%	Shares	Defined	2022-05-02
2021-12-31	$178,911	6,180	—	Shares	Defined	2022-01-28
No filing history on record for this holder in this stock.